期刊文献+

鸦胆子油乳注射液联合DX方案治疗晚期胃癌临床研究 被引量:11

Treatment of advanced gastric cancer with DX chemotherapy and Bruceolic Oil Emulsion
暂未订购
导出
摘要 目的探讨鸦胆子油乳注射液联合DX方案治疗晚期胃癌的临床疗效。方法 78例晚期胃癌患者采用住院号单双数随机分为治疗组(40例)和对照组(38例),治疗组采用鸦胆子油乳注射液联合DX方案化疗,对照组单用DX方案化疗,21天为1个周期,均化疗2个周期评价疗效及化疗后的毒副反应。结果治疗组近期有效率(CR+PR)为65%,对照组为39.5%,两组比较差异有统计学意义(χ2=5.09,P<0.05);两组化疗后毒副反应主要为骨髓抑制和腹泻,治疗组骨髓抑制发生率为37.5%,对照组为73.7%,两组比较差异有统计学意义(χ2=5.14,P<0.05),治疗组腹泻的发生率也明显低于对照组(χ2=9.58,P<0.05);治疗组生活质量(KPS)显著高于对照组(P<0.05)。结论鸦胆子油乳注射液联合DX方案治疗晚期胃癌有一定作用,可明显提高患者的近期有效率和生活质量,保护免疫功能,减轻化疗的毒副反应。 Objective To study the clinical efficacy of DX chemotherapy and Bruceolic Oil Emulsion for advanced gastric cancer.Methods A total of 78 patients with advanced gastric cancer were divided into two groups randomly.The 40 patients in the treatment group were treated with DX chemotherapy and Bruceolic Oil Emulsion while the 38 patients in control group were treated with DX chemotherapy only.The chemotherapy last for 2 cycles with 3 weeks as a cycle.Results The effective rates in treatment group and control group were 65% and 39.5% respectively.There was significant difference between the two groups(P0.05).The major side effects of the two groups were bone marrow depression and diarrhea.Incidence of bone marrow suppression in treatment group was 37.5% while that in control group was 73.7%.There was significant difference between the two groups(P0.05).Incidence of diarrhea in treatment group was significantly lower than that in control group(P0.05).Conclusion It is an effective way to treat advanced gastric cancer with DX chemotherapy and Bruceolic Oil Emulsion,which benefits the patients by improving their life quality,protecting immune functions and reducing side effects after chemotherapy.
出处 《实用医院临床杂志》 2010年第6期76-77,共2页 Practical Journal of Clinical Medicine
关键词 晚期胃癌 DX方案化疗 鸦胆子油乳注射液 Gastric cancer DX Chem-otherapy Bruceolic Oil Emulsion
  • 相关文献

参考文献13

  • 1梁海斯.肝动脉栓塞化疗联合三维适形放疗治疗原发性肝癌门静脉癌栓23例效果分析[J].实用医院临床杂志,2009,6(5):54-56. 被引量:9
  • 2Ajani JA,Fodor MB,Tjulandin SA,et al..Phase Ⅱ multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated,advanced gastric,or gastroesophageal adenocarcinoma[J].J Clin Oncol,2005,23(24):5660-5667.
  • 3Moiseyenko VM,Ajani JA,Tjulandin SA,et al..Final Results of arandomized controlled phase Ⅲ trial(TAX 325)comparing docetaxel(T)combined with cisplatin(C)and 5-fluomuracil(F)to CF in patients with metastatic gastric adenocarcinoma[J].Proc Am Soc Clin Oncol,2005,23:4002.
  • 4AI-Batran S,Hartmann JT,Probst S,et al..A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemothempywith fluorouracil,leucovorin and oxalip latin(FLO)versus fluorouracil,leucovorin and cisptatin(FLP).2006 ASCO Annual Meeting Proceedings(Post-Meeting Edition)[J].J Clin Oncol,2006,24(18S):4016.
  • 5唐三元,伍尤华,朱平风.多西紫杉醇联合顺铂与紫杉醇联合顺铂治疗晚期非小细胞肺癌疗效比较[J].实用医院临床杂志,2007,4(3):54-56. 被引量:1
  • 6侯梅,李慧,李潞,朱江.奥沙利铂联合氟尿嘧啶亚叶酸钙治疗晚期胃癌[J].实用医院临床杂志,2004,1(2):47-48. 被引量:3
  • 7Kim TW,Kang YK,Ahn JH,et al..Phase Ⅱ study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer[J].Ann Oncol,2002,13(12):1893-1898.
  • 8Jin ML,Shen L,Hu B,et al..Mature data on capecitabine(X)+fractionated cisplatin(P)as first-line therapy in patients with advanced gastric carcinoma.2006 ASCO Annual Meeting Proceeding(Post-Meeting Edition)[J].J Clin Oncol,2006,24(18):4075.
  • 9Cunningham D,Rao S,Starling N,et al..Randomised multicentrephase Ⅱ study comparing capecitabine with fluorouracil and ox-aliplatin with cisplatin in patients with advanced oesophagogastric(OG)cancer:The real-trial.2006 ASCO Annual Meeting Proceedings(Post-Meeting Edition)[J].J Clin Oncol,2006,24(18s):4017.
  • 10胡成平.肺癌的化疗耐药问题及对策[J].中华结核和呼吸杂志,2008,31(12):886-888. 被引量:4

二级参考文献23

共引文献42

同被引文献156

引证文献11

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部